Century Therapeutics (IPSC) Institutional Ownership $0.54 +0.00 (+0.02%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$0.55 +0.00 (+0.70%) As of 08/22/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Century Therapeutics (NASDAQ:IPSC)CurrentInstitutional OwnershipPercentage50.20%Number ofInstitutional Buyers(last 12 months)27TotalInstitutional Inflows(last 12 months)$6.39MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$3.10M Get IPSC Insider Trade Alerts Want to know when executives and insiders are buying or selling Century Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPSC Institutional Buying and Selling by Quarter Century Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Jane Street Group LLC444,590$248K0.0%N/A0.516% 8/14/2025 Raymond James Financial Inc.91,323$51K0.0%N/A0.106% 8/14/2025 Qube Research & Technologies Ltd67,737$38K0.0%N/A0.079% 8/13/2025 Marshall Wace LLP139,707$78K0.0%N/A0.162% 8/12/2025 Prudential Financial Inc.45,400$25K0.0%N/A0.053% 8/8/2025 Geode Capital Management LLC380,277$213K0.0%-60.8%0.441% 8/1/2025 Y Intercept Hong Kong Ltd89,975$50K0.0%N/A0.104% 6/27/2025 Goldman Sachs Group Inc.179,635$86K0.0%+26.9%0.208% 5/21/2025 Acadian Asset Management LLC284,229$133K0.0%+101.2%0.330% 5/16/2025 Goldman Sachs Group Inc.179,635$86K0.0%+26.9%0.208% Get the Latest News and Ratings for IPSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Century Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 AQR Capital Management LLC111,079$53K0.0%+358.9%0.129% 5/15/2025 Baker BROS. Advisors LP241,684$115K0.0%-69.7%0.281% 5/12/2025 Nuveen LLC157,311$75K0.0%N/A0.183% 5/9/2025 Deutsche Bank AG96,140$46K0.0%-50.3%0.112% 5/9/2025 Charles Schwab Investment Management Inc.270,820$129K0.0%-24.3%0.314% 2/17/2025 VR Adviser LLC3,957,186$4.00M0.3%-26.6%4.654% 2/17/2025 Squarepoint Ops LLC164,871$167K0.0%+56.0%0.194% 2/17/2025 Two Sigma Investments LP66,797$67K0.0%N/A0.079% 2/17/2025 Two Sigma Advisers LP51,000$52K0.0%N/A0.060% 2/17/2025Nuveen Asset Management LLC157,311$159K0.0%+48.9%0.185% 2/17/2025 Millennium Management LLC1,607,174$1.62M0.0%+1,041.8%1.890% 2/17/2025 Deutsche Bank AG193,368$195K0.0%+890.7%0.227% 2/17/2025 Casdin Capital LLC5,190,506$5.24M0.3%+61.6%6.104% 2/17/2025 Bank of America Corp DE66,043$67K0.0%+109.1%0.078% 2/14/2025 Jane Street Group LLC48,036$49K0.0%+166.2%0.056% 2/14/2025 Northern Trust Corp336,989$340K0.0%-4.4%0.396% 2/13/2025 Marshall Wace LLP35,511$36K0.0%N/A0.042% 2/13/2025 XTX Topco Ltd85,993$87K0.0%N/A0.101% 2/13/2025 Renaissance Technologies LLC1,202,885$1.22M0.0%+146.4%1.415% 2/12/2025 Geode Capital Management LLC991,595$1.00M0.0%+2.4%1.166% 2/12/2025 JPMorgan Chase & Co.163,189$165K0.0%+127.5%0.192% 2/11/2025 Sei Investments Co.52,748$53K0.0%N/A0.062% 12/26/2024 JPMorgan Chase & Co.71,721$123K0.0%+257.6%0.084% 11/19/2024 Barclays PLC61,945$106K0.0%+283.6%0.073% 11/16/2024 Geode Capital Management LLC968,182$1.66M0.0%+3.5%1.139% 11/15/2024 Barclays PLC61,945$106K0.0%+283.6%0.073% 11/15/2024 Jane Street Group LLC18,044$31K0.0%-77.6%0.021% 11/15/2024 Wellington Management Group LLP166,123$284K0.0%N/A0.195% 11/15/2024 State Street Corp836,914$1.43M0.0%+7.4%0.984% 11/13/2024 FMR LLC2,521,511$4.31M0.0%-14.5%2.965% He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now11/12/2024 Charles Schwab Investment Management Inc.355,331$608K0.0%-10.8%0.418% 11/6/2024 Cornercap Investment Counsel Inc.25,978$44K0.0%-49.1%0.031% 10/3/2024 SG Americas Securities LLC16,081$27K0.0%N/A0.019% 8/9/2024 Renaissance Technologies LLC165,500$422K0.0%+6.1%0.196% 8/9/2024 Dimensional Fund Advisors LP75,315$192K0.0%+141.7%0.089% 8/8/2024 Federated Hermes Inc.276,163$704K0.0%-55.1%0.327% 8/1/2024 Rhumbline Advisers52,466$134K0.0%+56.0%0.062% 7/26/2024 Bank of New York Mellon Corp149,000$380K0.0%+110.1%0.176% 5/16/2024 Jacobs Levy Equity Management Inc.293,941$1.23M0.0%+191.0%0.453% 5/10/2024 Vanguard Group Inc.1,138,653$4.76M0.0%+1.2%1.757% 5/1/2024 Mirae Asset Global Investments Co. Ltd.11,130$47K0.0%N/A0.017% 2/28/2024 Abel Hall LLC10,071$33K0.0%N/A0.017% 2/14/2024 Avidity Partners Management LP1,355,000$4.50M0.2%+23.4%2.265% 2/6/2024 New York Life Investment Management LLC99,912$332K0.0%-2.6%0.167% 1/31/2024 Federated Hermes Inc.618,482$2.05M0.0%+0.4%1.034% 11/14/2023 Avidity Partners Management LP1,098,500$2.20M0.1%-1.1%1.836% 11/13/2023 FMR LLC4,524,629$9.05M0.0%-12.5%7.562% 11/8/2023 New York Life Investment Management LLC102,606$205K0.0%-13.6%0.172% 8/7/2023 Acadian Asset Management LLC50,078$157K0.0%-18.6%0.084% 8/7/2023 New York Life Investment Management LLC118,771$375K0.0%-11.3%0.199% 5/12/2023 Martingale Asset Management L P49,151$171K0.0%N/A0.082% 5/11/2023 Cornercap Investment Counsel Inc.52,175$181K0.0%N/A0.088% 5/9/2023 Gladius Capital Management LP7,730$27K0.0%N/A0.013% 5/8/2023 New York Life Investment Management LLC133,829$464K0.0%N/A0.225% 2/9/2023 Mirae Asset Global Investments Co. Ltd.12,622$65K0.0%N/A0.021% 2/2/2023 SG Americas Securities LLC10,368$53K0.0%N/A0.018% 1/23/2023 Allspring Global Investments Holdings LLC7,992$41K0.0%N/A0.014% 11/15/2022 Logos Global Management LP460,075$4.55M0.6%-3.5%0.780% 11/14/2022 Point72 Asset Management L.P.165,200$1.63M0.0%-65.7%0.281% 11/14/2022 HarbourVest Partners LLC29,018$287K0.1%+98.3%0.049% 11/7/2022 Nisa Investment Advisors LLC12,000$126K0.0%N/A0.020% 11/3/2022 Parametrica Management Ltd27,840$275K0.6%-3.5%0.047% 8/16/2022 DAFNA Capital Management LLC475,367$3.99M1.1%+85.0%0.807% 8/16/2022Delphia USA Inc.10,548$89K0.1%N/A0.018% 8/15/2022 Point72 Asset Management L.P.481,000$4.04M0.0%+2.9%0.817% 8/12/2022 FMR LLC7,576,385$63.64M0.0%-7.9%12.874% 8/8/2022 Walleye Capital LLC78,698$661K0.0%+54.6%0.134% 7/29/2022 Russell Investments Group Ltd.3,308$27K0.0%N/A0.006% 7/22/2022 Parametrica Management Ltd28,855$241K0.3%N/A0.049% 5/27/2022 Walleye Capital LLC50,908$641K0.0%-18.5%0.087% 5/16/2022 Deep Track Capital LP926,469$11.66M0.7%+270.6%1.575% 5/5/2022 New York State Common Retirement Fund13,651$172K0.0%+76.9%0.023% 3/3/2022 Walleye Capital LLC62,471$991K0.0%N/A0.114% 2/19/2022 Woodline Partners LP208,082$3.30M0.0%-16.8%0.381% 2/15/2022 Marshall Wace LLP701,338$11.12M0.0%+528.7%1.284% 2/14/2022 Point72 Asset Management L.P.410,800$6.52M0.0%N/A0.752% 2/14/2022 DAFNA Capital Management LLC100,135$1.59M0.4%+25.2%0.183% 2/14/2022 Deep Track Capital LP250,000$3.97M0.3%N/A0.458% 2/14/2022 HarbourVest Partners LLC14,631$232K0.0%N/A0.027% 2/8/2022 ProShare Advisors LLC10,273$163K0.0%N/A0.019% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $72/7/2022 Royce & Associates LP12,900$205K0.0%N/A0.024% 2/2/2022 New York State Common Retirement Fund7,718$122K0.0%+267.5%0.014% 1/28/2022 Allspring Global Investments Holdings LLC15,545$246K0.0%N/A0.028% 11/16/2021 Schonfeld Strategic Advisors LLC13,600$342K0.0%-24.9%0.025% 11/16/2021 Metropolitan Life Insurance Co NY3,737$94K0.0%N/A0.007% 11/15/2021 Marshall Wace LLP111,552$2.81M0.0%+111.5%0.205% 11/12/2021 Ghisallo Capital Management LLC15,000$377K0.0%-50.0%0.028% 11/12/2021 Parametrica Management Ltd28,755$723K0.5%N/A0.053% 11/12/2021 Geode Capital Management LLC204,691$5.15M0.0%+429.4%0.376% 11/10/2021 Citigroup Inc.1,335$34K0.0%N/A0.002% (Data available from 1/1/2016 forward) IPSC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPSC shares? During the previous two years, 43 institutional investors and hedge funds held shares of Century Therapeutics. The most heavily invested institutionals were Casdin Capital LLC ($5.24M), Vanguard Group Inc. ($4.76M), Avidity Partners Management LP ($4.50M), FMR LLC ($4.31M), VR Adviser LLC ($4.00M), Millennium Management LLC ($1.62M), and State Street Corp ($1.43M).Learn more on Century Therapeutics' institutional investors. What percentage of Century Therapeutics' stock is owned by institutional investors? 50.20% of Century Therapeutics' stock is owned by institutional investors. Learn more on IPSC's institutional investor holdings. Which institutional investors have been buying Century Therapeutics' stock? Of the 36 institutional investors that purchased Century Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Casdin Capital LLC ($1.98M), Millennium Management LLC ($1.47M), Renaissance Technologies LLC ($724.19K), Jane Street Group LLC ($474.58K), Avidity Partners Management LP ($256.50K), Jacobs Levy Equity Management Inc. ($192.92K), and Marshall Wace LLP ($175.22K). How much institutional buying is happening at Century Therapeutics? Institutional investors have bought a total of 6,672,736 shares in the last 24 months. This purchase volume represents approximately $6.39M in transactions. Which of Century Therapeutics' major shareholders have been selling company stock? Of the 9 institutional investors that sold Century Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: VR Adviser LLC ($1.43M), Geode Capital Management LLC ($589.98K), Baker BROS. Advisors LP ($555.78K), FMR LLC ($428.77K), Charles Schwab Investment Management Inc. ($130.03K), Deutsche Bank AG ($97.23K), and Jane Street Group LLC ($62.59K). How much institutional selling is happening at Century Therapeutics? Institutional investors have sold a total of 3,337,010 shares in the last 24 months. This volume of shares sold represents approximately $3.10M in transactions. Related Companies VYGR Major Shareholders CYBN Major Shareholders LYEL Major Shareholders MEIP Major Shareholders LFVN Major Shareholders CTNM Major Shareholders TVGN Major Shareholders ACTU Major Shareholders GLSI Major Shareholders ELDN Major Shareholders This page (NASDAQ:IPSC) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Century Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Century Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access